Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
about
Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC)PaGenBase: a pattern gene database for the global and dynamic understanding of gene functionThe Goat (Capra hircus) Mammary Gland Mitochondrial Proteome: A Study on the Effect of Weight Loss Using Blue-Native PAGE and Two-Dimensional Gel ElectrophoresisEvaluation and optimization of mass spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass analyzersPolymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma.Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.Polymeric immunoglobulin receptor expression is predictive of poor prognosis in glioma patients.Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryValidation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines.Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.Identification of gene expression changes from colitis to CRC in the mouse CAC modelInferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.Proteomics analysis of bodily fluids in pancreatic cancerQuantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay.Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.Strategies for discovering novel pancreatic cancer biomarkers.iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance.Proteomic analysis of Plasmodium falciparum parasites from patients with cerebral and uncomplicated malariaComparative Proteomic Analysis of Whole-Gut Lavage Fluid and Pancreatic Juice Reveals a Less Invasive Method of Sampling Pancreatic SecretionsLaminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesIn-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma.Glycocapture-based proteomics for secretome analysis.Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.Proteomic profiling of the cancer cell secretome: informing clinical research.Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.
P2860
Q28387627-3C4C55C9-370A-4A30-AFDF-EDB4CA8A822CQ28535589-F6B783FF-667D-4F4F-B28C-E9239D46546FQ28551096-D97271B6-BDE9-4DCF-825D-8F9DD03BD061Q30621030-D118CDAD-1535-4F7B-B346-1EA5700754F5Q33747680-1B4A7263-B60C-44CD-B276-922989EA01E2Q33991653-26D2CBC4-C21D-4B80-A8E4-587102C2061FQ34167166-07F7C6D5-0B84-4D2B-AC3A-E73F4F67D6E0Q34239193-3C157FEB-8689-4CB8-B1ED-E2DCE2882C0AQ34518517-30DFDAC8-BC1F-4DCF-918A-327DE14AFA58Q34566554-5B1C934F-57FF-4EFB-8903-7281DCFB2B34Q34657038-D0A3F962-41E2-49F9-80F2-A58FAF29BB33Q34768090-C3CB37A2-F76D-4E3A-8756-E3C7EDBFCD56Q34979033-6723EDCD-7A9A-4FA6-A38A-A692CAD3BC5EQ35151772-5BE65111-56A7-4AAD-AB14-BA30E104FCEAQ35154283-7AF1CC9E-1B32-493C-A4E3-832B75C1A34EQ35920900-053D4057-7F69-4ED3-AB6B-488909B5EB01Q36144177-6B35B309-7827-44C3-9061-A6BE9E10300EQ36243548-02F559C6-2CDE-49DE-A56E-C6C7F1D5CF40Q36579311-307E2062-8CCC-40B5-A537-0F0AE7C02507Q36857512-2034C45F-9C5D-409D-BBBA-1F6291952A1CQ36953353-DD76431A-8C4F-4232-87CB-9B5548058825Q36970506-25D90372-158E-4486-8988-8B93071F6003Q37214680-6B00E386-6C54-4C01-BC7A-790F8B691726Q37225469-8B587BD5-2B74-478B-9A5E-92D7C16E6ED4Q37372321-D905668F-853E-4F8B-9CC7-B147D5092022Q37457607-CA16040E-77AC-4BEE-B1D7-3B0D5A6F4512Q37520614-24F191D0-E918-45DF-B8B5-2B59EFFA52FAQ37707027-8D48C48F-6CB7-4DE2-8A77-6623CA632D9FQ38063829-A3F72B12-5DD8-4088-A373-4D0716FC3C33Q38268568-6DF8ADBF-F28E-4530-B1C6-1978E5FCBF13Q38659528-D17F9F9D-9E09-4D9A-8E9A-6F90E3CC7875Q38777938-971CAB4A-5A99-4CC9-8B35-46AD4F9B4976Q38834179-4AF19242-A596-43E3-BD6E-51A7F14FF50EQ38931288-E71048BF-CD09-4074-BE51-E1B65C51F232Q39188239-0AEBBCFC-9AD2-43D7-A25D-91AA923B84F9Q39198796-418F20E6-5519-476F-8EC9-3579271DB484Q39293549-1321CE0C-7109-44CC-84F4-733DD5C12804Q39468169-02924634-FBEB-4852-A9D5-AC3FBD0E58D6Q47154567-E9608C20-AE06-4A2B-8B50-C565269EF85AQ50868942-98F7F6AE-F741-4E8D-AC81-4C5AC1CFC43D
P2860
Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@ast
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@en
type
label
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@ast
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@en
prefLabel
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@ast
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@en
P2093
P2860
P50
P356
P1476
Integrated proteomic profiling ...... pancreatic cancer biomarkers.
@en
P2093
Chris Smith
Felix Rückert
Ihor Batruch
Shalini Makawita
Yingye Zheng
P2860
P304
M111.008599
P356
10.1074/MCP.M111.008599
P577
2011-06-07T00:00:00Z